Market Cap: $1.79M
TI
TransCode Therapeutics, Inc.
RNAZ
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $1.79M
Analysts estimated RNAZ earnings of $-91.68 per share this quarter (Q4). RNAZ's actual earnings were $-150.64 per share.
RNAZ EPS surprise of -64.31%Analysts estimated RNAZ earnings of $-16.49 per share this quarter (Q3). RNAZ's actual earnings were $-5.28 per share.
RNAZ EPS surprise of 67.99%Analysts estimated RNAZ earnings of $-0.59 per share this quarter (Q2). RNAZ's actual earnings were $-0.72 per share.
RNAZ EPS surprise of -21.70%Analysts estimated RNAZ earnings of $-0.71 per share this quarter (Q1). RNAZ's actual earnings were $-0.54 per share.
RNAZ EPS surprise of 24.37%Analysts estimated RNAZ earnings of $-11.02 per share this quarter (Q4). RNAZ's actual earnings were $-22.84 per share.
RNAZ EPS surprise of 107.33%Analysts estimated RNAZ earnings of $-61.20 per share this quarter (Q3). RNAZ's actual earnings were $-67.20 per share.
RNAZ EPS surprise of 9.80%